Credit Suisse started coverage of food concessions group SSP at 'underperform' with a 220. 0p target price, telling clients that the multiple headwinds from the Covid-19 pandemic were set to be stronger and be longer-lasting than what analysts were anticipating.
John Lewis' new chair, Sharon White, is looking to axe jobs, close part of its London headquarters and cancel its salary bonus as part of a cost-cutting programme.
US stocks closed mixed on the first day of trading in the new quarter amid "encouraging" clinical data from Pfizer and BioNTech on the study of a Covid-19 vaccine candidate.
Stocks in Europe finished well off their lows of the session driven by a rally in travel and leisure issues after positive news out of the US on one of the lead candidates for a vaccine against Covid-19.
The market spotlight on Thursday will be firmly on the US jobs market, with both weekly and monthly data set to coincide ahead of the 4 July holiday which would be observed during the following day.
Qinetiq revealed on Wednesday that non-executive director Susan Searle had acquired 10,000 ordinary shares in the FTSE 250-listed science and engineering group.
London’s benchmark closed just below the waterline after a choppy session on Wednesday, amid ongoing concerns about the coronavirus pandemic - particularly in the United States - and as investors eyed the latest readings on the UK's housing and manufacturing sectors.
Analysts at Berenberg lowered their target price on equipment rental company Ashtead from 2,000p to 1,750p on Wednesday, stating the group's recent share price performance had defied "softness" in lead indicators.
London’s FTSE 250 was up 0. 6% at 17,215. 25 in afternoon trade on Wednesday.
Analysts at Liberum hiked their target price on British logistics outfit DX from 14. 0p to 30. 0p on Wednesday, stating the group had executed "a remarkable turnaround".
Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary, ProBiotix Health, has entered into a non-exclusive distribution agreement with Actial Farmaceutica for the distribution of its ‘CholBiome’ and ‘CholBiome X3’ products, in four new territories in the Asia-Pacific region.
Advanced materials engineering group Versarien said on Wednesday that its full-year results had been delayed until August as a result of the Covid-19 pandemic and associated lockdowns.
Manufacturing in the US picked up the tempo significantly last month, but economists were at pains to stress that it was doing so from still "very depressed" levels of activity.
Gold and nickel exploration and development company Katoro Gold updated the market on its Blyvoor joint venture on Wednesday, in respect of the Blyvoor gold tailings project, reporting that the joint venture management and technical team would be conducting an “extensive” site visit on 1 and 2 July.
US stocks opened higher on the first day of trading in the new quarter after Pfizer and BioNTech released "encouraging" clinical data from the study of Covid-19 vaccine candidate, BNT162b1.
Fund manager Liontrust Asset Management has entered into a conditional sale and purchase agreement with AXA subsidiary Architas, it announced on Wednesday, to purchase the entirety of Architas Multi-Manager (AMML) and Architas Advisory Services (AASL), for a total consideration of up to £75m.
Harvey Weinstein’s bankrupt film studio agreed to pay a $47m settlement that will allocate over $20m towards dozens of victims who accused the film mogul of sexual assault and harassment.
US businesses continued to bring workers back from furlough throughout June as the country's economy attempted to slowly return to normal.
Analysts at Berenberg lowered their target price on equipment rental company Ashtead from 2,000. 0p to 1,750. 0p on Wednesday, stating the group's recent share price performance had defied "softness" in lead indicators.
Shares of drug giant Pfizer were boosted by news of positive clinical trial results for a Covid-19 vaccine candidate known as BNT162b1.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.